OncoSec Medical (ONCS) Stock: Climbing On Collaboration News

OncoSec Medical ONCS Stock News

OncoSec Medical Inc (NASDAQ: ONCS) is having a great day in the market today, and for good reason. The comapny announced collaboration news, exciting investors and sending the stock on a run for the top. Today, we’ll talk about: The collaboration news; what we’re seeing from ONCS stock as a result; and what we’ll be … Read more

OncoSec Medical (ONCS) Stock: Finding Its Way Up On Encouraging Results

OncoSec Medical Inc (NASDAQ: ONCS) is having an overwhelmingly strong day in the market today, and for good reason. The company released promising data with regard to the treatment of breast cancer. Today, we’ll talk about the data, what we’re seeing from the stock, and what we’ll be watching for ahead. ONCS Gains On Encouraging … Read more

OncoSec Medical (ONCS) Stock: Presents Clinical Overview

OncoSec Medical Inc (NASDAQ: ONCS) released some big news this morning. The company announced through a press release that it presented an overview of the comprehensive immune monitoring data from the Phase 3 clinical trial surrounding ImmunoPulse®. Here’s what we saw from the release… ONCS Presents Clinical Data As mentioned above, OncoSec Medical has presented … Read more

Memo To Inovio (INO) And Oncosec (ONCS): Investor Roadshows Are Dead

Zed’s dead, baby, Zed’s dead. And for the most part, so are those small-cap investor roadshows, who’s sponsor fill their prospective clients with the promise of analyst exposure and investor interest, only to find their stocks falling flat, despite the five digit expense paid to these so-called exposure specialists. Need first-hand proof, look at the … Read more

OncoSec Medical (ONCS) Stock: Gains Big On Fast Track Designation

OncoSec Medical Inc (NASDAQ: ONCS) OncoSec Medical is likely to have an incredibly strong day in the market today, if the pre-market movement on the stock is any indication of what we’re going to see. In the pre-market, the stock is climbing dramatically. Below, we’ll talk about what we’re seeing, why, and what we’ll be … Read more